Discover Our Peptide Portfolio In 2023, the FDA reviewed several peptides nominated for compounding and placed many on the 503A Category 2 list.[3] Then in 2024, the agency cited limited clinical safety data, along with concerns about immunogenicity (how the immune system might respond) and dosing variability.[4] It was a precautionary decision, and precaution is an important part of regulatory oversight
Weight loss peptides vary dramatically in their cost-effectiveness ratios when analyzed this way
Published Nexus variants include 5mg, 10mg, 15mg, 20mg, 30mg, 40mg, 50mg, 60mg
Efficacy and safety of Tirzepatide in type 2 diabetes and obesity management
Which is better for wrinkles, retinol or copper peptides
Biochimica et Biophysica Acta